Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trialFlorence Ader, Raphaël Clère-Jehl, Maude Bouscambert‐Duchamp et al.|The Lancet Infectious Diseases|2021Cited by 344
Attributable mortality of ICU-acquired bloodstream infections: Impact of the source, causative micro-organism, resistance profile and antimicrobial therapyChristophe Adrie, Hakim Haouache, Jean‐François Timsit et al.|Journal of Infection|2016Cited by 167
Relationship between ventilator-associated pneumonia and mortality in COVID-19 patients: a planned ancillary analysis of the coVAPid cohortSaad Nseir, Thierry Van Der Linden, Ignacio Martín‐Loeches et al.|Critical Care|2021Cited by 105
Early Bacterial Identification among Intubated Patients with COVID-19 or Influenza Pneumonia: A European Multicenter Comparative Clinical TrialAnahita Rouzé, Saad Nseir, Ignacio Martín‐Loeches et al.|American Journal of Respiratory and Critical Care Medicine|2021Cited by 103
Invasive pulmonary aspergillosis among intubated patients with SARS-CoV-2 or influenza pneumonia: a European multicenter comparative cohort studyAnahita Rouzé, Luís Coelho, Elise Lemaître et al.|Critical Care|2022Cited by 80